4//SEC Filing
Chan Heng Fai Ambrose 4
Accession 0001641172-25-025294
CIK 0000771999other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 7:30 PM ET
Size
9.0 KB
Accession
0001641172-25-025294
Insider Transaction Report
Form 4
DSS, INC.DSS
CHAN FAI
Director10% Owner
Transactions
- Other
Common Stock
2025-08-20$0.86/sh+581,395$500,000→ 581,395 total(indirect: See footnote)Exercise: $0.86From: 2025-08-20Exp: 2028-07-31→ Common Stock (581,395 underlying)
Alset Inc.
10% Owner
Transactions
- Other
Common Stock
2025-08-20$0.86/sh+581,395$500,000→ 581,395 total(indirect: See footnote)Exercise: $0.86From: 2025-08-20Exp: 2028-07-31→ Common Stock (581,395 underlying)
Footnotes (2)
- [F1]On August 20, 2025, the Issuer issued a convertible promissory note (the "Convertible Note") to Alset Inc. in the amount of $500,000.00. Under the terms of the Convertible Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of $0.86 per share.
- [F2]The beneficial ownership of Mr. Chan includes a total of 6,730,059 shares of common stock, consisting of (a) 1,002,978 shares of common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of common stock held by Mr. Chan directly; (c) 2,581,268 shares of common stock and debt convertible into 581,395 shares of common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) 1,068,309 shares of common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (e) 311,634 shares of common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.).
Documents
Issuer
DSS, INC.
CIK 0000771999
Entity typeother
Related Parties
1- filerCIK 0001261725
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 7:30 PM ET
- Size
- 9.0 KB